BR0011902A - Compostos derivados de ciclopentano substituìdo, respectivos processos de preparação e formas cristalinas - Google Patents
Compostos derivados de ciclopentano substituìdo, respectivos processos de preparação e formas cristalinasInfo
- Publication number
- BR0011902A BR0011902A BR0011902-4A BR0011902A BR0011902A BR 0011902 A BR0011902 A BR 0011902A BR 0011902 A BR0011902 A BR 0011902A BR 0011902 A BR0011902 A BR 0011902A
- Authority
- BR
- Brazil
- Prior art keywords
- substituted
- crystalline forms
- preparation processes
- respective preparation
- formula
- Prior art date
Links
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 125000001511 cyclopentyl group Chemical class [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 title 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000001940 cyclopentanes Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"COMPOSTOS DERIVADOS DE CICLOPENTANO SUBSTITUìDOS RESPECTIVOS PROCESSOS DE PREPARAçãO E FORMAS CRISTALINAS". A invenção refere-se a um processo de preparação de derivados de ciclopentano substituído representados pela fórmula (I), em que R^ 1^, R^ 2^, R^ 3^, R^ 4^, X e Y são conforme descritos no Relatório Descritivo, e seus sais farmaceuticamente aceitáveis. A invenção ainda se refere a um processo de purificação do composto de fórmula (Ia) e novas formas cristalinas do composto de fórmula (Ia).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14130199P | 1999-06-28 | 1999-06-28 | |
PCT/US2000/016013 WO2001000571A1 (en) | 1999-06-28 | 2000-06-09 | Process for preparing substituted cyclopentane derivatives and novel crystalline structures thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0011902A true BR0011902A (pt) | 2002-03-19 |
Family
ID=22495095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0011902-4A BR0011902A (pt) | 1999-06-28 | 2000-06-09 | Compostos derivados de ciclopentano substituìdo, respectivos processos de preparação e formas cristalinas |
Country Status (16)
Country | Link |
---|---|
US (1) | US6576786B2 (pt) |
EP (1) | EP1214294A1 (pt) |
JP (2) | JP4262920B2 (pt) |
KR (1) | KR20020022727A (pt) |
CN (1) | CN1367776A (pt) |
AR (1) | AR024494A1 (pt) |
AU (1) | AU5732700A (pt) |
BR (1) | BR0011902A (pt) |
CA (1) | CA2377240A1 (pt) |
CZ (1) | CZ20014657A3 (pt) |
HU (1) | HUP0202097A2 (pt) |
IL (1) | IL147244A0 (pt) |
NO (1) | NO20016389L (pt) |
PL (1) | PL213231B1 (pt) |
SK (1) | SK19042001A3 (pt) |
WO (1) | WO2001000571A1 (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001000571A1 (en) * | 1999-06-28 | 2001-01-04 | Ortho-Mcneil Pharmaceutical, Inc. | Process for preparing substituted cyclopentane derivatives and novel crystalline structures thereof |
AU2001243253A1 (en) * | 2000-02-24 | 2001-09-03 | Biocryst Pharmaceuticals, Inc. | Prodrugs of substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors |
US7405336B2 (en) * | 2004-10-18 | 2008-07-29 | Fina Technology, Inc. | Promoters for controlling acidity and pore size of zeolite catalysts for use in alkylation |
WO2007087056A2 (en) * | 2006-01-13 | 2007-08-02 | Scolr Pharma, Inc. | Peramivir derivative for oral administration |
CN101420948A (zh) | 2006-02-13 | 2009-04-29 | 拜奥克里斯特制药公司 | 静脉内抗病毒治疗 |
US20070244193A1 (en) * | 2006-04-12 | 2007-10-18 | Babu Yarlagadda S | Intramuscular antiviral treatments |
JP2008162935A (ja) * | 2006-12-28 | 2008-07-17 | Daicel Chem Ind Ltd | アミド又はラクタムの製造法 |
CN101367750B (zh) | 2007-08-14 | 2012-05-23 | 中国人民解放军军事医学科学院毒物药物研究所 | (1s,2s,3s,4r)-3-[(1s)-1-乙酰氨-2-乙基-丁基]-4-胍基-2-羟基-环戊基-1-羧酸水合物及其医药用途 |
CN102584637B (zh) * | 2011-01-17 | 2014-07-09 | 天津药物研究院 | 帕拉米韦水合物晶体、制备方法、药用组合物及其用途 |
CN102757365B (zh) * | 2011-04-29 | 2013-10-30 | 上海泓博智源医药技术有限公司 | 一种制备帕拉米韦关键中间体的方法 |
CN102372657B (zh) * | 2011-11-14 | 2014-04-09 | 暨南大学 | 一种抗流感及禽流感病毒药物帕拉米韦的合成方法 |
CN102863359B (zh) * | 2012-05-16 | 2014-05-07 | 常州制药厂有限公司 | 一种抗流感药物的合成方法 |
CN105198827A (zh) * | 2015-04-13 | 2015-12-30 | 广州南新制药有限公司 | 一种帕拉米韦中间体的合成方法 |
CN108997171B (zh) * | 2018-06-21 | 2020-11-27 | 苏州正济医药研究有限公司 | 一种3+2关环的合成方法 |
CN112250601B (zh) * | 2020-09-08 | 2022-09-27 | 天津应天成科技有限公司 | 安全无毒去除帕拉米韦三水合物中间体m9中镍离子杂质的方法 |
CN114181117B (zh) * | 2020-09-15 | 2023-05-05 | 南京正济医药研究有限公司 | 一种帕拉米韦中间体的制备方法 |
CN116425659B (zh) * | 2023-03-02 | 2023-11-03 | 浙江康聚药业有限公司 | 一种合成帕拉米韦的方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9813480A (pt) * | 1997-12-17 | 2000-10-10 | Biocryst Pharm Inc | Compostos inibidores de neuraminidase de ciclopentano substituìdo, composição e métodos de inibição da neuraminidase do vìrus da influenza- e de tratamento de infecção por vìrus da influenza- |
WO2001000571A1 (en) * | 1999-06-28 | 2001-01-04 | Ortho-Mcneil Pharmaceutical, Inc. | Process for preparing substituted cyclopentane derivatives and novel crystalline structures thereof |
-
2000
- 2000-06-09 WO PCT/US2000/016013 patent/WO2001000571A1/en not_active Application Discontinuation
- 2000-06-09 KR KR1020017016653A patent/KR20020022727A/ko not_active Application Discontinuation
- 2000-06-09 PL PL352992A patent/PL213231B1/pl unknown
- 2000-06-09 EP EP00942747A patent/EP1214294A1/en not_active Withdrawn
- 2000-06-09 CN CN00809654A patent/CN1367776A/zh active Pending
- 2000-06-09 IL IL14724400A patent/IL147244A0/xx unknown
- 2000-06-09 HU HU0202097A patent/HUP0202097A2/hu unknown
- 2000-06-09 CZ CZ20014657A patent/CZ20014657A3/cs unknown
- 2000-06-09 AU AU57327/00A patent/AU5732700A/en not_active Abandoned
- 2000-06-09 BR BR0011902-4A patent/BR0011902A/pt not_active Application Discontinuation
- 2000-06-09 SK SK1904-2001A patent/SK19042001A3/sk unknown
- 2000-06-09 JP JP2001506983A patent/JP4262920B2/ja not_active Expired - Lifetime
- 2000-06-09 CA CA002377240A patent/CA2377240A1/en not_active Abandoned
- 2000-06-27 AR ARP000103219A patent/AR024494A1/es unknown
-
2001
- 2001-11-26 US US09/991,753 patent/US6576786B2/en not_active Expired - Lifetime
- 2001-12-27 NO NO20016389A patent/NO20016389L/no not_active Application Discontinuation
-
2008
- 2008-12-10 JP JP2008314190A patent/JP4597237B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
IL147244A0 (en) | 2002-08-14 |
CZ20014657A3 (cs) | 2002-10-16 |
HUP0202097A2 (en) | 2002-10-28 |
CN1367776A (zh) | 2002-09-04 |
JP4597237B2 (ja) | 2010-12-15 |
US6576786B2 (en) | 2003-06-10 |
NO20016389L (no) | 2002-02-21 |
JP2009073859A (ja) | 2009-04-09 |
KR20020022727A (ko) | 2002-03-27 |
US20020061930A1 (en) | 2002-05-23 |
NO20016389D0 (no) | 2001-12-27 |
AU5732700A (en) | 2001-01-31 |
WO2001000571A1 (en) | 2001-01-04 |
JP2003503384A (ja) | 2003-01-28 |
EP1214294A1 (en) | 2002-06-19 |
PL352992A1 (en) | 2003-09-22 |
JP4262920B2 (ja) | 2009-05-13 |
PL213231B1 (pl) | 2013-01-31 |
AR024494A1 (es) | 2002-10-02 |
SK19042001A3 (sk) | 2002-04-04 |
CA2377240A1 (en) | 2001-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0011902A (pt) | Compostos derivados de ciclopentano substituìdo, respectivos processos de preparação e formas cristalinas | |
BRPI0612957B8 (pt) | composto, processos de preparação de compostos, composição farmacêutica e uso de um composto | |
BR0108893B1 (pt) | composiÇço farmacÊutica contendo derivados de azetidina, composto derivado de azetidina, e, processo para a preparaÇço de compostos. | |
BR0316470A (pt) | Derivados de 3-amino-piperadina e métodos de preparação | |
BR0209241A (pt) | Processo para preparação de derivados de9-deoxo-9a-aza-9a-homoeritromicina a 4-substituida | |
ES2159491A1 (es) | Base cristalina de citalopram | |
BR0317435A (pt) | Derivados de pirimidina para o tratamento do crescimento celular anormal | |
BR0307267A (pt) | Compostos heterocìclicos, ativos como inibidores de beta-lacta-mases | |
NO20072689L (no) | Tetrasykliske indolderivater som antivirale midler | |
MXPA05013752A (es) | Procedimiento e intermediarios para la preparacion de (1r,2s,5s)-6,6-dimetil-3-azabiciclo[3,1,0]exan-2-carboxilatos o sales de los mismos. | |
BRPI0608245A2 (pt) | compostos; processo para a sua fabricação; composições farmacêuticas; método para o tratamento e/ou prevenção de doenças que estejam associadas à modulação de receptores de sst subtipo 5 e uso dos compostos | |
NO20054538L (no) | Fremgangsmate for fremstilling av antikonvulsantderivater av topiramat | |
NO20050088L (no) | Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav | |
WO2006027628A3 (en) | Naphthalimide derivatives as antiviral agents | |
BR0116571A (pt) | Compostos heterocìclicos tendo atividade antibacteriana, processo para sua preparação e composições farmacêuticas contendo os mesmos | |
NO20054135L (no) | Kipolinon/benzoksazin derivater og anvendelser derav | |
WO2005066167A3 (en) | 3-quinuclidinyl heteroatom bridged biaryl derivatives | |
BR0212069A (pt) | Agentes antidiabéticos orais | |
BRPI0414436A (pt) | processo para a preparação de derivados de 2-oxo-1-pirrolidina e seus sais | |
BRPI0409105A (pt) | análogos de quinobenzoxazina substituìdos | |
BRPI0409465A (pt) | derivados de carboxamida como agentes antidiabéticos | |
BR0010139A (pt) | Heterociclos bicìclicos substituìdos, processo para seu preparo e seu uso como agentes anti-obesidade e hipocolesterolêmico | |
BRPI0501769A (pt) | Compostos de pirrolidina e tiazolidina, processo para sua preparação e composições farmacêuticas contendo os mesmos | |
BR0214937A (pt) | Processo de preparação de derivados de equinocandina | |
BR0113259A (pt) | Processo para a preparação de um composto, composto e processo para a preparação de compostos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |